Prostate bed irradiation with alternative radio-oncological approaches (PAROS): a prospective, multicenter and randomized phase III trial

For patients with treatment-naïve carcinoma of the prostate, hypofractionated irradiation becomes more and more popular. Due to the low α/β value of prostate cancer, increased single dose leading to a shortened treatment period seems to be safe and feasible. However, reliable data is lacking for po...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Körber, Stefan A. (VerfasserIn) , Katayama, Sonja (VerfasserIn) , Sander, Anja (VerfasserIn) , Jäkel, Cornelia (VerfasserIn) , Häfner, Matthias (VerfasserIn) , Debus, Jürgen (VerfasserIn) , Herfarth, Klaus (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 10 July 2019
In: Radiation oncology
Year: 2019, Jahrgang: 14
ISSN:1748-717X
DOI:10.1186/s13014-019-1325-x
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s13014-019-1325-x
Volltext
Verfasserangaben:Stefan A. Koerber, Sonja Katayama, Anja Sander, Cornelia Jaekel, Matthias F. Haefner, Juergen Debus and Klaus Herfarth
Beschreibung
Zusammenfassung:For patients with treatment-naïve carcinoma of the prostate, hypofractionated irradiation becomes more and more popular. Due to the low α/β value of prostate cancer, increased single dose leading to a shortened treatment period seems to be safe and feasible. However, reliable data is lacking for post-prostatectomy patients so far. Further, the role of proton therapy is still under debate. Two prospective phase II trials with both, hypofractionated photon and proton therapy, provided promising results.
Beschreibung:Gesehen am 01.10.2019
Beschreibung:Online Resource
ISSN:1748-717X
DOI:10.1186/s13014-019-1325-x